(Q33698348)

28 July 2017

1 reference

title

Chemokines and chemokine receptors: role in HIV infection (English)

1 reference

28 July 2017

Kalinkovich A

1

1 reference

PubMed ID

10424433

28 July 2017

Weisman Z

series ordinal

2

1 reference

PubMed ID

10424433

28 July 2017

Bentwich Z

series ordinal

3

1 reference

28 July 2017

1 June 1999

1 reference

28 July 2017

1 reference

28 July 2017

68

1 reference

28 July 2017

281-287

1 reference

28 July 2017

2-3

1 reference

Chemokines--chemotactic cytokines that mediate inflammation

28 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2899%2900059-0

7 January 2021

Chemokines and T lymphocytes: more than an attraction.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2899%2900059-0

7 January 2021

Co-receptors for HIV-1 entry

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2899%2900059-0

7 January 2021

Chemokine receptors: keys to AIDS pathogenesis?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2899%2900059-0

7 January 2021

Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2899%2900059-0

7 January 2021

The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2899%2900059-0

7 January 2021

A new classification for HIV-1

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2899%2900059-0

7 January 2021

CCR5 chemokine receptor variant in HIV-1 mother-to-child transmission and disease progression in children. French Pediatric HIV Infection Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2899%2900059-0

7 January 2021

Impact of heterozygosity for the chemokine receptor CCR5 32-bp-deleted allele on plasma virus load and CD4 T lymphocytes in perinatally human immunodeficiency virus-infected children at 8 years of age.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2899%2900059-0

7 January 2021

HIV-1-infected long-term slow progressors heterozygous for delta32-CCR5 show significantly lower plasma viral load than wild-type slow progressors.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2899%2900059-0

7 January 2021

Mechanism of transdominant inhibition of CCR5-mediated HIV-1 infection by ccr5delta32.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2899%2900059-0

7 January 2021

Host genes and HIV: the role of the chemokine receptor gene CCR5 and its allele

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2899%2900059-0

7 January 2021

Distribution of the CCR5 gene 32-bp deletion in Europe

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2899%2900059-0

7 January 2021

Global distribution of the CCR5 gene 32-basepair deletion.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2899%2900059-0

7 January 2021

HIV-1-resistance phenotype conferred by combination of two separate inherited mutations of CCR5 gene.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2899%2900059-0

7 January 2021

CCR5 promoter polymorphism and HIV-1 disease progression. Multicenter AIDS Cohort Study (MACS).

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2899%2900059-0

7 January 2021

Contrasting Genetic Influence of CCR2 and CCR5 Variants on HIV-1 Infection and Disease Progression

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2899%2900059-0

7 January 2021

CCR2 Polymorphism and HIV Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2899%2900059-0

7 January 2021

A chemokine receptor CCR2 allele delays HIV-1 disease progression and is associated with a CCR5 promoter mutation.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2899%2900059-0

7 January 2021

CCR2-64I allele and genotype association with delayed AIDS progression in African women. University of Nairobi Collaboration for HIV Research

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2899%2900059-0

7 January 2021

Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant. ALIVE Study, Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SF

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2899%2900059-0

7 January 2021

AIDS: a role for host genes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2899%2900059-0

7 January 2021

Relative resistance to HIV-1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high-risk sexual exposure

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2899%2900059-0

7 January 2021

Molecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophils

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2899%2900059-0

7 January 2021

Cloning, expression, and characterization of the human eosinophil eotaxin receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2899%2900059-0

7 January 2021

Chemokine-independent in vitro resistance to human immunodeficiency virus (HIV-1) correlating with low viremia in long-term and recently infected HIV-1-positive persons

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2899%2900059-0

7 January 2021

Chemokine production in HIV-seropositive long-term asymptomatic individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2899%2900059-0

7 January 2021

Circulating levels of RANTES in human immunodeficiency virus type 1 infection: effect of potent antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2899%2900059-0

7 January 2021

C-C chemokines, pivotal in protection against HIV type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2899%2900059-0

7 January 2021

Production of beta-chemokines in human immunodeficiency virus (HIV) infection: evidence that high levels of macrophage inflammatory protein-1beta are associated with a decreased risk of HIV disease progression

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2899%2900059-0

7 January 2021

Do beta-chemokines have clinical relevance in HIV infection?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2899%2900059-0

7 January 2021

The CXC chemokine stromal cell-derived factor 1 is not responsible for CD8+ T cell suppression of syncytia-inducing strains of HIV-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2899%2900059-0

7 January 2021

Inhibition of HIV-1 infection by the beta-chemokine MDC

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2899%2900059-0

7 January 2021

CCR5 is characteristic of Th1 lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2899%2900059-0

7 January 2021

Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2899%2900059-0

7 January 2021

The Th1-Th2 hypothesis of HIV infection: new insights

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2899%2900059-0

7 January 2021

Dual effect of interleukin 4 on HIV-1 expression: implications for viral phenotypic switch and disease progression

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2899%2900059-0

7 January 2021

Interleukin 10 increases CCR5 expression and HIV infection in human monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2899%2900059-0

7 January 2021

Interleukin-2 inhibits HIV-1 replication in human macrophages by modulating expression of CD4 and CC-chemokine receptor-5.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2899%2900059-0

7 January 2021

The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2899%2900059-0

7 January 2021

Preferential infection of CD4+ memory T cells by human immunodeficiency virus type 1: evidence for a role in the selective T-cell functional defects observed in infected individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2899%2900059-0

7 January 2021

Differential susceptibility of naive and memory CD4+ T cells to the cytopathic effects of infection with human immunodeficiency virus type 1 strain LAI.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2899%2900059-0

7 January 2021

Expression patterns of the HIV type 1 coreceptors CCR5 and CXCR4 on CD4+ T cells and monocytes from cord and adult blood

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2899%2900059-0

7 January 2021

HIV infection of CD45RA+ and CD45RO+ CD4+ T cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2899%2900059-0

7 January 2021

CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1, in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2899%2900059-0

7 January 2021

Differential regulation of HIV-1 fusion cofactor expression by CD28 costimulation of CD4+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2899%2900059-0

7 January 2021

CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2899%2900059-0

7 January 2021

Naïve and memory CD4 T cells differ in their susceptibilities to human immunodeficiency virus type 1 infection following CD28 costimulation: implicatip6s for transmission and pathogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2899%2900059-0

7 January 2021

CCR5 expression correlates with susceptibility of maturing monocytes to human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2899%2900059-0

7 January 2021

Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2899%2900059-0

7 January 2021

Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2899%2900059-0

7 January 2021

Genetic Restriction of HIV-1 Infection and Progression to AIDS by a Deletion Allele of the CKR5 Structural Gene

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2899%2900059-0

7 January 2021

Reduced HIV-1 infectability of CD4+ lymphocytes from exposed-uninfected individuals: association with low expression of CCR5 and high production of beta-chemokines

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2899%2900059-0

7 January 2021

HIV-1 subtype and second-receptor use

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2899%2900059-0

7 January 2021

Exposure to bacterial products renders macrophages highly susceptible to T-tropic HIV-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2899%2900059-0

7 January 2021

Mycobacterium avium complex augments macrophage HIV-1 production and increases CCR5 expression

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2899%2900059-0

7 January 2021

Immune dysregulation in Ethiopian immigrants in Israel: relevance to helminth infections?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2899%2900059-0

7 January 2021

Decreased CD4 and increased CD8 counts with T cell activation is associated with chronic helminth infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2899%2900059-0

7 January 2021

Immune activation is a dominant factor in the pathogenesis of African AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2899%2900059-0

7 January 2021

HIV coreceptor downregulation as antiviral principle: SDF-1alpha-dependent internalization of the chemokine receptor CXCR4 contributes to inhibition of HIV replication

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2899%2900059-0

7 January 2021

Potent inhibition of HIV-1 infectivity in macrophages and lymphocytes by a novel CCR5 antagonist.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2899%2900059-0

7 January 2021

HIV blocked by chemokine antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2899%2900059-0

7 January 2021

Rare mutations in a domain crucial for V3-loop structure prevail in replicating HIV from long-term non-progressors.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2899%2900059-0

7 January 2021

Bicyclams, a class of potent anti-HIV agents, are targeted at the HIV coreceptor fusin/CXCR-4.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2899%2900059-0

7 January 2021

Antiviral efficacy in vivo of the anti-human immunodeficiency virus bicyclam SDZ SID 791 (JM 3100), an inhibitor of infectious cell entry

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2899%2900059-0

7 January 2021

AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2899%2900059-0

7 January 2021

Chemokines and HIV-1 second receptors: the therapeutic connection

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2899%2900059-0

7 January 2021

Change in coreceptor use correlates with disease progression in HIV-1--infected individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2899%2900059-0

7 January 2021

In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2899%2900059-0

7 January 2021

Repertoire of chemokine receptor expression in the female genital tract: implications for human immunodeficiency virus transmission

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2899%2900059-0

7 January 2021

10.1016/S0165-2478(99)00059-0

Identifiers

DOI

1 reference

28 July 2017

1 reference

PubMed ID

10424433